||The discovery of induced pluripotent stem cells (iPSCs) more than a decade ago has transformed stem cell biology and biomedical research in such fields as disease modeling, drug discovery, predictive toxicology and regenerative medicine applications. To bring iPSC-based therapies more efficiently to patients, it is pivotal to continue addressing the key knowledge gaps and roadblocks in a coordinated multidisciplinary fashion. This workshop will focus on defining the collaborative opportunities, challenges and best practices in translational iPSC research. Topics of interest are quality control standards for pluripotency, safety, experimental reproducibility, cost-efficient scalability and manufacturing, improved and efficient differentiation protocols, advances in -omics and functional characterization of cell-type identities, and other relevant questions. As a deliverable of the workshop, the gathered information and recommendations will help to draft a white paper for the translational stem cell community.